← Back to Search

Suicide Prevention Interventions for Autism

N/A
Recruiting
Led By Danielle Roubinov, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able and willing to provide informed consent (age ≥18) or assent and parental consent (age <18)
15-24 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patient participants: 1-month follow-up; clinician and health system leader participants: up to 4 years
Awards & highlights

Study Summary

This trial will compare two suicide prevention strategies to see which is more effective, feasible, and acceptable for autistic individuals.

Who is the study for?
This trial is for young people aged 15-24 with autism who have had suicidal thoughts or behaviors. They must speak English and have received a safety plan tailored for autistic youth during a clinical visit. Those over 18 can consent themselves, while those under need parental consent.Check my eligibility
What is being tested?
The study compares two suicide prevention strategies specifically designed for autistic individuals: one is the Safety Planning Intervention (SPI-A), and the other adds structured follow-up contacts to SPI-A (SPI-A+).See study design
What are the potential side effects?
Since this trial involves non-medical interventions focused on planning and follow-ups, there are no direct medical side effects; however, discussing sensitive topics like self-harm may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and can consent, or if under 18, my parents can consent for me.
Select...
I am between 15 and 24 years old.
Select...
I received a safety plan designed for autistic individuals during my clinic visit.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patient participants: 1-month follow-up; clinician and health system leader participants: up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and patient participants: 1-month follow-up; clinician and health system leader participants: up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feeling suicidal (finding)
Secondary outcome measures
Change in access to lethal means
Change in acute care services for suicidality
Therapeutic procedure
+6 more

Trial Design

2Treatment groups
Active Control
Group I: Safety Planning Intervention Tailored for Autistic IndividualsActive Control1 Intervention
The Safety Planning Intervention Tailored for Autistic individuals (SPI-A) is a brief collaborative intervention that results in an individually tailored plan designed to lower the short-term risk of suicide in autistic youth.
Group II: Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up ContactsActive Control1 Intervention
The Safety Planning Intervention Tailored for Autistic individuals plus structured follow-up contacts (SPI-A+) is a multi-component intervention comprised of SPI-A and structured follow-up consisting of at least 2 brief contacts.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,500 Previous Clinical Trials
4,175,053 Total Patients Enrolled
14 Trials studying Autism Spectrum Disorder
1,739 Patients Enrolled for Autism Spectrum Disorder
Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,994,723 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
1,586 Patients Enrolled for Autism Spectrum Disorder
University of PennsylvaniaOTHER
1,993 Previous Clinical Trials
42,873,898 Total Patients Enrolled
14 Trials studying Autism Spectrum Disorder
2,302 Patients Enrolled for Autism Spectrum Disorder

Media Library

Safety Planning Intervention tailored for Autistic Individuals Clinical Trial Eligibility Overview. Trial Name: NCT05398250 — N/A
Autism Spectrum Disorder Research Study Groups: Safety Planning Intervention Tailored for Autistic Individuals, Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts
Autism Spectrum Disorder Clinical Trial 2023: Safety Planning Intervention tailored for Autistic Individuals Highlights & Side Effects. Trial Name: NCT05398250 — N/A
Safety Planning Intervention tailored for Autistic Individuals 2023 Treatment Timeline for Medical Study. Trial Name: NCT05398250 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research accommodate individuals over 30 years of age?

"The eligibility requirements for this medical trial specify that participants must be between 15 and 99 years old. Meanwhile, there are 309 trials intended specifically for minors aged under 18, with 197 more catered to seniors over 65."

Answered by AI

What is the current geographic scope of this investigative endeavor?

"Four medical institutions are collaborating on this research including Nationwide Children's Hospital in Columbus, Kennedy Krieger Institute in Baltimore, and Children's Hospital of Pennsylvania in Philadelphia. Additionally, there are 4 additional sites engaged with the project."

Answered by AI

What criteria must one meet in order to be enrolled in this clinical trial?

"This trial, which seeks to recruit 1665 participants, offers the potential of participation for those with suicidal tendencies aged 15-99."

Answered by AI

Are there vacancies open to participants in this clinical investigation?

"Yes, according to clinicaltrials.gov this medical trial is still recruiting participants. It was initially posted on August 23rd 2022 and the last edit occurred October 11th of that same year."

Answered by AI

To what extent has patient participation been observed in this clinical research?

"Verified. Clinicaltrials.gov reveals that enrollment for this clinical trial is currently open. It was initially posted on August 23rd 2022 and has since been updated most recently on October 11th of the same year. 1665 participants must be sourced from 4 distinct sites in order to reach completion goals."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
What site did they apply to?
Nationwide Children's Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~1006 spots leftby Sep 2026